BNO bionomics limited
Add to My Watchlist 0.00% ! 1.0¢

anti-anxiety comp. bnc210 human clinical trial

  1. manfred1952
    613 Posts.
    lightbulb Created with Sketch. 58
    clock Created with Sketch.
    22/05/09
    09:19
    Post #: 5192747
    Australian biotechnology company Bionomics Limited
    (ASX:BNO) today announced that its lead anti-anxiety compound, BNC210, has
    successfully passed review and is approved to enter human clinical trials.
    Early bird catches the worm!
    BNO Price at posting: 24.9¢ Sentiment: None Disclosure: Held
    Likes Created with Sketch. 2  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS View the latest ASX market news here
right-arrow Created with Sketch.
NEWS Strategic investment secured for QLD and NSW bauxite projects
right-arrow Created with Sketch.
NEWS Marquee declares maiden antimony resource at Eastern Hills with phase two exploration to commence
right-arrow Created with Sketch.
NEWS Drilling to commence at FAU’s Gimlet high-grade gold project following approvals
right-arrow Created with Sketch.
NEWS CLEO receives positive FDA feedback supporting ovarian cancer test pathway
right-arrow Created with Sketch.
NEWS Strong soil results define new gold targets at Tole and Dadjan
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.